Heart monitoring breakthrough: 14 days vs. 24 hours for MVP patients
NCT ID NCT06378996
First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study tests whether wearing a heart monitor for 14 days can detect dangerous heart rhythms in people with mitral valve prolapse (a common heart valve condition) better than the usual 24-hour test. About 60 adults with MVP will wear a patch monitor for two weeks. The goal is to see how often risky rhythms occur and how much they vary day-to-day, which could lead to better detection and future research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL VALVE PROLAPSE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UZ Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart scans may unlock hidden risks in minority communities
- Could a short course of steroids calm a dangerous heart rhythm?
- Heart valve repair showdown: which surgery works best?
- Can MRI predict dangerous heart rhythms in mitral valve prolapse?
- Can we safely skip the shock test during heart device implant?
- Old gout drug may tame deadly heart inflammation